Pure Global

Effect of Shotblocker and Palm Stimulator - Trial NCT06381804

Access comprehensive clinical trial information for NCT06381804 through Pure Global AI's free database. This phase not specified trial is sponsored by Necmettin Erbakan University and is currently Recruiting. The study focuses on Pain. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06381804
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06381804
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Shotblocker and Palm Stimulator
Effect of Shotblocker and Palm Stimulator in Reducing Pain Associated With Intramuscular Injection: A Randomized Controlled Trial

Study Focus

Pain

shotblocker

Interventional

other

Sponsor & Location

Necmettin Erbakan University

Meram, Turkey

Timeline & Enrollment

N/A

Apr 19, 2024

May 01, 2024

96 participants

Primary Outcome

Visual analog scale (VAS) pain Scale score

Summary

This study discusses the advancements in nursing, particularly focusing on intramuscular
 injections, their complications, and innovative non-pharmacological methods such as the
 Shotblocker and palm stimulator to reduce pain. These methods, based on the gate control
 theory, aim to minimize discomfort during injections by applying tactile stimulation, which
 has proven effective in various studies.

ICD-10 Classifications

Pain, unspecified
Pain, not elsewhere classified
Pain in limb
Acute pain
Other chronic pain

Data Source

ClinicalTrials.gov

NCT06381804

Non-Device Trial